Search research articles
Contact Us
Filters
Showing results (11-20 of 176) with videos related to
Page
of 18
Sort By:
Thoracic Cancer
|
November 2, 2016
Heterogeneity of the resistance to gefitinib treatment in a non-small cell lung cancer patient with active epidermal growth factor receptor mutation
Chong-Rui Xu, Wen-Zhao Zhong, Qing Zhou, et al.
The International Journal of Biological Markers
|
July 23, 2013
Sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in males, smokers, and non-adenocarcinoma lung cancer in patients with EGFR mutations
Zhu Zeng, Hua-Jun Chen, Hong-Hong Yan, et al.
Nuclear Medicine Communications
|
September 22, 2011
Is ¹⁸F-fluorodeoxyglucose positron emission tomography-based metabolic response superior to Response Evaluation Criteria In Solid Tumors-based response after two cycles of platinum-based chemotherapy in predicting clinical outcome of untreated patients with advanced non-small cell lung cancer?
Jin-Ji Yang, Shu-Xia Wang, Wen-Zhao Zhong, et al.
BMC Cancer
|
October 16, 2015
Multiple primary malignancies involving lung cancer
Feng Li, Wen-Zhao Zhong, Fei-Yu Niu, et al.
Cancer Drug Resistance (Alhambra, Calif.)
|
March 7, 2025
Exploring YAP1-related TIME in SCLC: implications for survival and treatment response to immuno-chemotherapy
Yu-Qing Chen, Jia-Xiong Tan, Ling-Ling Gao, et al.
Thoracic Cancer
|
April 16, 2020
Mutational landscape and characteristics of ERBB2 in non-small cell lung cancer
Xue-Wu Wei, Xin Gao, Xu-Chao Zhang, et al.
Chinese Medical Journal
|
June 7, 2017
Establishment of a Novel Method for Screening Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance Mutations in Lung Cancer
Hong-Xia Tian, Xu-Chao Zhang, Zhen Wang, et al.
Pathology Oncology Research : POR
|
May 30, 2013
Disease flare after EGFR tyrosine kinase inhibitor cessation predicts poor survival in patients with non-small cell lung cancer
Hua-Jun Chen, Hong-Hong Yan, Jin-Ji Yang, et al.
BMC Cancer
|
September 21, 2014
A randomized phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in locally advanced or metastatic squamous cell carcinoma of lung
Jin-Ji Yang, Cheng Huang, Gong-Yan Chen, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 28, 2017
Clinical characteristics and sequence complexity of anaplastic lymphoma kinase gene fusions in Chinese lung cancer patients
Hong-Xia Tian, Xu-Chao Zhang, Jin-Ji Yang, et al.
Page
of 18
Search research articles
Search
Showing results (11-20 of 176) with videos related to
Sort By:
Page
of 18
Thoracic Cancer
|
November 2, 2016
Heterogeneity of the resistance to gefitinib treatment in a non-small cell lung cancer patient with active epidermal growth factor receptor mutation
Chong-Rui Xu, Wen-Zhao Zhong, Qing Zhou, et al.
The International Journal of Biological Markers
|
July 23, 2013
Sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in males, smokers, and non-adenocarcinoma lung cancer in patients with EGFR mutations
Zhu Zeng, Hua-Jun Chen, Hong-Hong Yan, et al.
Nuclear Medicine Communications
|
September 22, 2011
Is ¹⁸F-fluorodeoxyglucose positron emission tomography-based metabolic response superior to Response Evaluation Criteria In Solid Tumors-based response after two cycles of platinum-based chemotherapy in predicting clinical outcome of untreated patients with advanced non-small cell lung cancer?
Jin-Ji Yang, Shu-Xia Wang, Wen-Zhao Zhong, et al.
BMC Cancer
|
October 16, 2015
Multiple primary malignancies involving lung cancer
Feng Li, Wen-Zhao Zhong, Fei-Yu Niu, et al.
Cancer Drug Resistance (Alhambra, Calif.)
|
March 7, 2025
Exploring YAP1-related TIME in SCLC: implications for survival and treatment response to immuno-chemotherapy
Yu-Qing Chen, Jia-Xiong Tan, Ling-Ling Gao, et al.
Thoracic Cancer
|
April 16, 2020
Mutational landscape and characteristics of ERBB2 in non-small cell lung cancer
Xue-Wu Wei, Xin Gao, Xu-Chao Zhang, et al.
Chinese Medical Journal
|
June 7, 2017
Establishment of a Novel Method for Screening Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance Mutations in Lung Cancer
Hong-Xia Tian, Xu-Chao Zhang, Zhen Wang, et al.
Pathology Oncology Research : POR
|
May 30, 2013
Disease flare after EGFR tyrosine kinase inhibitor cessation predicts poor survival in patients with non-small cell lung cancer
Hua-Jun Chen, Hong-Hong Yan, Jin-Ji Yang, et al.
BMC Cancer
|
September 21, 2014
A randomized phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in locally advanced or metastatic squamous cell carcinoma of lung
Jin-Ji Yang, Cheng Huang, Gong-Yan Chen, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 28, 2017
Clinical characteristics and sequence complexity of anaplastic lymphoma kinase gene fusions in Chinese lung cancer patients
Hong-Xia Tian, Xu-Chao Zhang, Jin-Ji Yang, et al.
Page
of 18